Shawn SCHILLER

Person

Haverhill, MA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Inhibiting deubiquitinase USP25 and USP28
- Patent number 12,252,490
- Issue date Mar 18, 2025
- Valo Health, Inc.
- David J. Guerin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds and uses thereof
- Patent number 12,139,487
- Issue date Nov 12, 2024
- Foghorn Therapeutics Inc.
- Shawn E. R. Schiller
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Tetrahydro-imidazo quinoline compositions as CBP/P300 inhibitors
- Patent number 11,787,803
- Issue date Oct 17, 2023
- Forma Therapeutics, Inc.
- Shawn E. R. Schiller
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds and uses thereof
- Patent number 11,497,752
- Issue date Nov 15, 2022
- Foghorn Therapeutics Inc.
- Neville John Anthony
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Thienopyrazine carboxamides as ubiquitin-specific protease inhibitors
- Patent number 11,325,917
- Issue date May 10, 2022
- Valo Health, Inc.
- David Joseph Guerin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Tetrahydro-imidazo quinoline compositions as CBP/P300 inhibitors
- Patent number 11,292,791
- Issue date Apr 5, 2022
- Forma Therapeutics, Inc.
- Shawn E. R. Schiller
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Solid forms of (4-(2-fluoro-4-(1-methyl-1H-benzo[d]imidazol-5-yl)be...
- Patent number 11,267,805
- Issue date Mar 8, 2022
- Forma Therapeutics, Inc.
- George P. Luke
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibiting CREB binding protein (CBP)
- Patent number 11,254,674
- Issue date Feb 22, 2022
- Forma Therapeutics, Inc.
- Shawn E. R. Schiller
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Tetrahydropyrazolopyrimidine compounds
- Patent number 11,130,758
- Issue date Sep 28, 2021
- Eisai R&D Management Co., Ltd.
- Roch Boivin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Tetrahydroquinoline compositions as BET bromodomain inhibitors
- Patent number 11,111,229
- Issue date Sep 7, 2021
- Forma Therapeutics, Inc.
- Kenneth W. Bair
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Benzopiperazine compositions as BET bromodomain inhibitors
- Patent number 11,084,831
- Issue date Aug 10, 2021
- Forma Therapeutics, Inc.
- Kenneth W. Bair
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds and compositions for inhibition of FASN
- Patent number 10,995,078
- Issue date May 4, 2021
- Forma Therapeutics, Inc.
- Kenneth W. Bair
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Thienopyridine carboxamides as ubiquitin-specific protease inhibitors
- Patent number 10,913,753
- Issue date Feb 9, 2021
- Valo Early Discovery, Inc.
- David Joseph Guerin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Thienopyrazine carboxamides as ubiquitin-specific protease inhibitors
- Patent number 10,889,592
- Issue date Jan 12, 2021
- Valo Early Discovery, Inc.
- David Joseph Guerin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibiting CREB binding protein (CBP)
- Patent number 10,870,648
- Issue date Dec 22, 2020
- Forma Therapeutics, Inc.
- Shawn E. R. Schiller
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds and compositions for inhibition of FASN
- Patent number 10,800,750
- Issue date Oct 13, 2020
- Forma Therapeutics, Inc.
- Kenneth W. Bair
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Benzopiperazine compositions as BET bromodomain inhibitors
- Patent number 10,703,764
- Issue date Jul 7, 2020
- Forma Therapeutics, Inc.
- Kenneth W. Bair
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Tetrahydropyrazolopyrimidine compounds
- Patent number 10,640,500
- Issue date May 5, 2020
- Eisai R&D Management Co., Ltd.
- Roch Boivin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Tetrahydroquinoline compositions as bet bromodomain inhibitors
- Patent number 10,611,750
- Issue date Apr 7, 2020
- Forma Therapeutics, Inc.
- Kenneth W. Bair
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds and compositions for inhibition of FASN
- Patent number 10,472,342
- Issue date Nov 12, 2019
- Forma Therapeutics, Inc.
- Kenneth W. Bair
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds and compositions for inhibition of FASN
- Patent number 10,457,655
- Issue date Oct 29, 2019
- Forma Therapeutics, Inc.
- Kenneth W. Bair
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds and compositions for inhibition of FASN
- Patent number 10,450,286
- Issue date Oct 22, 2019
- Forma Therapeutics, Inc.
- Kenneth W. Bair
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds and compositions for inhibition of FASN
- Patent number 10,399,951
- Issue date Sep 3, 2019
- Forma Therapeutics, Inc.
- Kenneth W. Bair
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Benzopiperazine compositions as BET bromodomain inhibitors
- Patent number 10,377,769
- Issue date Aug 13, 2019
- Forma Therapeutics, Inc.
- Kenneth W. Bair
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Tetrahydroquinoline compositions as BET bromodomain inhibitors
- Patent number 10,336,722
- Issue date Jul 2, 2019
- Forma Therapeutics, Inc.
- Kenneth W. Bair
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Selectively substituted quinoline compounds
- Patent number RE47193
- Issue date Jan 8, 2019
- Eisai R&D Management Co., Ltd.
- J. Eric Carlson
Information Patent Grant
Selectively substituted quinoline compounds
- Patent number 10,087,174
- Issue date Oct 2, 2018
- Eisai R&D Management Co., Ltd.
- J. Eric Carlson
- G01 - MEASURING TESTING
Information Patent Grant
Tetrahydropyrazolopyrimidine compounds
- Patent number 9,850,242
- Issue date Dec 26, 2017
- Eisai R&D Management Co., Ltd.
- Roch Boivin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Selectively substituted quinoline compounds
- Patent number 9,663,486
- Issue date May 30, 2017
- Eisai R&D Management Co., Ltd.
- Roch Boivin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Tetrahydropyrazolopyrimidine compounds
- Patent number 9,446,046
- Issue date Sep 20, 2016
- Eisai R&D Management Co., Ltd.
- Roch Boivin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
COMPOUNDS AND USES THEREOF
- Publication number 20250066354
- Publication date Feb 27, 2025
- Foghorn Therapeutics Inc.
- Shawn E.R. SCHILLER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TETRAHYDRO-IMIDAZO QUINOLINE COMPOSITIONS AS CBP/P300 INHIBITORS
- Publication number 20240150349
- Publication date May 9, 2024
- Forma Therapeutics, Inc.
- Shawn E.R. Schiller
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS AND USES THEREOF
- Publication number 20230416248
- Publication date Dec 28, 2023
- Foghorn Therapeutics Inc.
- Kevin J. WILSON
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUNDS AND USES THEREOF
- Publication number 20230365560
- Publication date Nov 16, 2023
- Foghorn Therapeutics Inc.
- Shawn E.R. SCHILLER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUNDS AND USES THEREOF
- Publication number 20230348452
- Publication date Nov 2, 2023
- Foghorn Therapeutics Inc.
- Matthew NETHERTON
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS AND USES THEREOF
- Publication number 20230149414
- Publication date May 18, 2023
- Foghorn Therapeutics Inc.
- Neville John ANTHONY
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS AND USES THEREOF
- Publication number 20230145003
- Publication date May 11, 2023
- Foghorn Therapeutics Inc.
- Kevin J. WILSON
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUNDS AND USES THEREOF
- Publication number 20230138480
- Publication date May 4, 2023
- Foghorn Therapeutics Inc.
- Neville John ANTHONY
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS AND USES THEREOF
- Publication number 20230121497
- Publication date Apr 20, 2023
- Foghorn Therapeutics Inc.
- Rishi G. VASWANI
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS AND USES THEREOF
- Publication number 20230079819
- Publication date Mar 16, 2023
- Foghorn Therapeutics Inc.
- Rishi G. VASWANI
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TETRAHYDROQUINOLINE COMPOSITIONS AS BET BROMODOMAIN INHIBITORS
- Publication number 20230061891
- Publication date Mar 2, 2023
- Forma Therapeutics, Inc.
- Kenneth W. BAIR
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHIBITING CYCLIC AMP-RESPONSIVE ELEMENT-BINDING PROTEIN (CREB)
- Publication number 20220213089
- Publication date Jul 7, 2022
- Forma Therapeutics, Inc.
- Shawn E.R. SCHILLER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TETRAHYDRO-IMIDAZO QUINOLINE COMPOSITIONS AS CBP/P300 INHIBITORS
- Publication number 20220169647
- Publication date Jun 2, 2022
- Forma Therapeutics, Inc.
- Shawn E.R. Schiller
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHIBITING CREB BINDING PROTEIN (CBP)
- Publication number 20220162207
- Publication date May 26, 2022
- Forma Therapeutics, Inc.
- Shawn E.R. Schiller
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS AND USES THEREOF
- Publication number 20220119378
- Publication date Apr 21, 2022
- Foghorn Therapeutics Inc.
- Neville John ANTHONY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL COMPOUNDS AND COMPOSITIONS FOR INHIBITION OF FASN
- Publication number 20210214323
- Publication date Jul 15, 2021
- Forma Therapeutics, Inc.
- Kenneth W. Bair
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHIBITING DEUBIQUITINASE USP25 AND USP28
- Publication number 20210179628
- Publication date Jun 17, 2021
- Valo Early Discovery, Inc.
- David J. GUERIN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
THIENOPYRAZINE CARBOXAMIDES AS UBIQUITIN-SPECIFIC PROTEASE INHIBITORS
- Publication number 20210047343
- Publication date Feb 18, 2021
- Valo Early Discovery, Inc.
- David Joseph Guerin
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS AND USES THEREOF
- Publication number 20210038611
- Publication date Feb 11, 2021
- Foghorn Therapeutics Inc.
- Neville John ANTHONY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SOLID FORMS OF (4-(2-FLUORO-4-(1-METHYL-1H-BENZO[d]IMIDAZOL-5-YL)BE...
- Publication number 20200392114
- Publication date Dec 17, 2020
- Forma Therapeutics, Inc.
- George P. LUKE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TETRAHYDROQUINOLINE COMPOSITIONS AS BET BROMODOMAIN INHIBITORS
- Publication number 20200369642
- Publication date Nov 26, 2020
- Forma Therapeutics, Inc.
- Kenneth W. BAIR
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TETRAHYDROPYRAZOLOPYRIMIDINE COMPOUNDS
- Publication number 20200347050
- Publication date Nov 5, 2020
- Eisai R&D Management Co., Ltd.
- Roch Boivin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUNDS AND COMPOSITIONS FOR INHIBITION OF FASN
- Publication number 20200347025
- Publication date Nov 5, 2020
- Forma Therapeutics, Inc.
- Kenneth W. Bair
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHIBITING CREB BINDING PROTEIN (CBP)
- Publication number 20200299295
- Publication date Sep 24, 2020
- Forma Therapeutics, Inc.
- Shawn E.R. Schiller
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TETRAHYDRO-IMIDAZO QUINOLINE COMPOSITIONS AS CBP/P300 INHIBITORS
- Publication number 20200216445
- Publication date Jul 9, 2020
- Forma Therapeutics, Inc.
- Shawn E.R. Schiller
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL COMPOUNDS AND COMPOSITIONS FOR INHIBITION OF FASN
- Publication number 20200017458
- Publication date Jan 16, 2020
- FORMA Therapeutics, Inc.
- Kenneth W. Bair
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Thienopyridine Carboxamides as Ubiquitin-Specific Protease Inhibitors
- Publication number 20200017525
- Publication date Jan 16, 2020
- Forma Therapeutics, Inc.
- David Joseph Guerin
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INHIBITING CREB BINDING PROTEIN (CBP)
- Publication number 20200002332
- Publication date Jan 2, 2020
- Forma Therapeutics, Inc.
- Shawn E.R. Schiller
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Thienopyrazine Carboxamides as Ubiquitin-Specific Protease Inhibitors
- Publication number 20190359628
- Publication date Nov 28, 2019
- Forma Therapeutics, Inc.
- David Joseph Guerin
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BENZOPIPERAZINE COMPOSITIONS AS BET BROMODOMAIN INHIBITORS
- Publication number 20190330233
- Publication date Oct 31, 2019
- Forma Therapeutics, Inc.
- Kenneth W. BAIR
- C07 - ORGANIC CHEMISTRY

Shawn SCHILLER

Person

Patents Grantslast 30 patents

Inhibiting deubiquitinase USP25 and USP28

Compounds and uses thereof

Tetrahydro-imidazo quinoline compositions as CBP/P300 inhibitors

Compounds and uses thereof

Thienopyrazine carboxamides as ubiquitin-specific protease inhibitors

Tetrahydro-imidazo quinoline compositions as CBP/P300 inhibitors

Solid forms of (4-(2-fluoro-4-(1-methyl-1H-benzo[d]imidazol-5-yl)be...

Inhibiting CREB binding protein (CBP)

Tetrahydropyrazolopyrimidine compounds

Tetrahydroquinoline compositions as BET bromodomain inhibitors

Benzopiperazine compositions as BET bromodomain inhibitors

Compounds and compositions for inhibition of FASN

Thienopyridine carboxamides as ubiquitin-specific protease inhibitors

Thienopyrazine carboxamides as ubiquitin-specific protease inhibitors

Inhibiting CREB binding protein (CBP)

Compounds and compositions for inhibition of FASN

Benzopiperazine compositions as BET bromodomain inhibitors

Tetrahydropyrazolopyrimidine compounds

Tetrahydroquinoline compositions as bet bromodomain inhibitors

Compounds and compositions for inhibition of FASN

Compounds and compositions for inhibition of FASN

Compounds and compositions for inhibition of FASN

Compounds and compositions for inhibition of FASN

Benzopiperazine compositions as BET bromodomain inhibitors

Tetrahydroquinoline compositions as BET bromodomain inhibitors

Selectively substituted quinoline compounds

Selectively substituted quinoline compounds

Tetrahydropyrazolopyrimidine compounds

Selectively substituted quinoline compounds

Tetrahydropyrazolopyrimidine compounds

Patents Applicationslast 30 patents

COMPOUNDS AND USES THEREOF

TETRAHYDRO-IMIDAZO QUINOLINE COMPOSITIONS AS CBP/P300 INHIBITORS

COMPOUNDS AND USES THEREOF

COMPOUNDS AND USES THEREOF

COMPOUNDS AND USES THEREOF

COMPOUNDS AND USES THEREOF

COMPOUNDS AND USES THEREOF

COMPOUNDS AND USES THEREOF

COMPOUNDS AND USES THEREOF

COMPOUNDS AND USES THEREOF

TETRAHYDROQUINOLINE COMPOSITIONS AS BET BROMODOMAIN INHIBITORS

INHIBITING CYCLIC AMP-RESPONSIVE ELEMENT-BINDING PROTEIN (CREB)

TETRAHYDRO-IMIDAZO QUINOLINE COMPOSITIONS AS CBP/P300 INHIBITORS

INHIBITING CREB BINDING PROTEIN (CBP)

COMPOUNDS AND USES THEREOF

NOVEL COMPOUNDS AND COMPOSITIONS FOR INHIBITION OF FASN

INHIBITING DEUBIQUITINASE USP25 AND USP28

THIENOPYRAZINE CARBOXAMIDES AS UBIQUITIN-SPECIFIC PROTEASE INHIBITORS

COMPOUNDS AND USES THEREOF

SOLID FORMS OF (4-(2-FLUORO-4-(1-METHYL-1H-BENZO[d]IMIDAZOL-5-YL)BE...

TETRAHYDROQUINOLINE COMPOSITIONS AS BET BROMODOMAIN INHIBITORS

TETRAHYDROPYRAZOLOPYRIMIDINE COMPOUNDS

COMPOUNDS AND COMPOSITIONS FOR INHIBITION OF FASN

INHIBITING CREB BINDING PROTEIN (CBP)

TETRAHYDRO-IMIDAZO QUINOLINE COMPOSITIONS AS CBP/P300 INHIBITORS

NOVEL COMPOUNDS AND COMPOSITIONS FOR INHIBITION OF FASN

Thienopyridine Carboxamides as Ubiquitin-Specific Protease Inhibitors

INHIBITING CREB BINDING PROTEIN (CBP)

Thienopyrazine Carboxamides as Ubiquitin-Specific Protease Inhibitors

BENZOPIPERAZINE COMPOSITIONS AS BET BROMODOMAIN INHIBITORS